Do not start sodium valproate for the first time in people (male or female) younger than 55 years, unless 2 specialists independently agree and document that there is no other effective and tolerated ...

A phase 3 study assessing the use pregabalin as adjunctive therapy for epilepsy patients 5 to 65 years of age with primary generalized tonic-clonic (PGTC) seizures did not meet its primary endpoint to ...

On September 16, SK Biopharmaceuticals announced that it has obtained positive top-line results from a Phase 3 clinical trial evaluating cenobamate (U.S. brand name XCOPRI®), its innovative ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that 24-month data on generalized tonic-clonic (GTC) seizures in people with drug-resistant epilepsy (DRE) ...

The FDA also approved Vimpat Injection for use in pediatric patients 4 years of age and older. The Food and Drug Administration (FDA) has approved Vimpat ® (lacosamide; UCB) as adjunctive therapy in ...

A multicenter cohort study explores how the timing of ASM withdrawal after epilepsy surgery may influence seizure relapse and ...

November is Epilepsy Awareness Month. Many people may already be aware of the condition from its prevalence in medical dramas, but that portrayal is often exaggerated and does not fully encapsulate ...

Jon Kyle Andersen refreshes our knowledge on common medical emergencies. You have full access to this article via your institution. A severe, life-threatening, generalised or systemic hypersensitivity ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. In 2020, Aaron Pura was training at the police academy in ...